Supplementary
. Effects of whey, lactalbumin and lactoferrin on feed efficiency and energy expenditure. (a) Feed efficiency and (b) daily energy expenditure normalized to body weight. Feed efficiency was expressed as the ratio of weekly weight gain to the amount of food consumed in gm, and energy expenditure as the ratio of total heat produced (kcal) to body weight (kg). Rats were fed either normal protein (control) diet (CON; green circles), or high protein diets enriched with whey protein isolate (WH; red square), α-lactalbumin (LA; blue triangle), lactoferrin (LF; orange diamond), or pair-fed (PF; inverted purple triangle) to LF, for 56 days. Values are expressed as mean ± SEM, n = 8/group. *P ≤ 0.05 vs CON, # P ≤ 0.05 LF vs PF, b P≤ 0.05 LF vs WH.
Supplementary Figure 2. Effects of whey, lactalbumin and lactoferrin on plasma hormones.
Area-Under-the-Curve analyses for (a) IPGTT 4 weeks, (b) IPGTT at 8 weeks, (c) blood glucose following meal challenge, and plasma concentrations of (d) insulin, (e) leptin, (f) glucosedependent insulinotropic polypeptide (GIP), (g) amylin, and (h) peptide YY (PYY), and (i) glucagon-like peptide-1 (GLP-1) following a meal challenge at 8 weeks. Rats were fed either normal protein (control) diet (CON; green bars), or high protein diets enriched with whey protein isolate (WH; red bars), α-lactalbumin (LA; blue bars), lactoferrin (LF; orange bars) or pair-fed (PF; purple bars) to LF, for 56 days. Values are expressed as mean ± SEM, n = 8/group. Bars without a common letter differ.
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Supplementary Figure 3. Effects of whey, lactalbumin and lactoferrin on hepatic lipidosis.
Hematoxylin-eosin stained (magnification 100X) and (b) Periodic Acid-Schiff stained (40X) liver sections from rats fed diets containing either control, whey protein isolate, α-lactalbumin, lactoferrin, or pair-fed to lactoferrin.
Supplementary Figure 4.
Representative immunoblots for (a) Na + -K + -ATPase (b) Membranebound Insulin receptor beta chain (IRb) and GLUT4 (c) Total IRb and GLUT4 and (d) GAPDH in skeletal muscles from rats fed diets containing either normal protein (control) diet (CON), or high protein diets enriched with whey protein isolate (WH), α-lactalbumin (LA), lactoferrin (LF), or pair-fed to lactoferrin (PF). The samples derive from the same experiments, the gels and blots were processed in parallel, and the blots were re-probed for membrane bound and total IRb and GLUT4. The animal numbers corresponding to each treatment (n = 6-8/treatment group) and molecular weight markers (RPN800E, GE Healthcare, Mississauga, ON, Canada) are also shown. Select bands from lanes 2-6 of each blot are cropped and presented in Figure 5 . *Slc2a2 -Glucose transporter -2; Pfkl -Phosphofructokinase (Liver); PfkmPhosphofructokinase (Muscle); Hk2 -Hexokinase; Gck -Glucokinase; Gys1 -Glycogen Synthase 1; Gys2 -Glycogen Synthase 2; G6pd -Glucose-6-Phosphate Dehydrogenase; Acaca -Acetyl-CoA Carboxylase 1; Fasn -Fatty Acid Synthase; Cpt1a -Carnitine palmitoyltransferase 1a; Pdha1 -Pyruvate Dehydrogenase; Ucp3 -Uncoupling Protein-3; Ppargc1a -peroxisome proliferator-activated receptor gamma co-activator 1α; Rps13 -Ribosomal protein S13; Actbactin, beta.
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